The importance of the baseline Disease Activity Score 28 in determining responders and non-responders to anti-TNF in UK clinical practice
Authors:
Open Access
- 4 April 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 47 (9) , 1389-1391
Abstract
Objectives. The NICE re-appraisal of anti-TNF requires demonstration of ongoing response, making the baseline 28-joint Disease Activity Score (DAS28) crucially important. A retrospective analysis of all RA patients on their first anti-TNF determined predictive factors for those classified as non-responders at 6 months according to current NICE guidelines. Methods. The patients were divided into responders (DAS28 dropped by >1.2) and non-responders. These groups were compared for demographics, DAS28 at the two pre-assessments 1 month apart and at baseline. Exposure to intramuscular, oral and IA steroids in the 3 months period before the baseline DAS28 was recorded. Results. At 6-month assessment in 256 patients, 82.8% were responders with no demographic differences between them and non-responders. Although the first pre-assessment score was not significantly different (6.8 vs 6.6), the second pre-assessment score (7.1 vs 6.7) and the baseline DAS (7.2 vs 6.3) were lower in the non-responders (P < 0.04 and P < 0.001, respectively). Comparing the differences in DAS28 from the first pre-assessment to baseline, the responders had increased by 0.4, and the non-responders had decreased by 0.4, (P < 0.001). If the first pre-assessment score had been taken as the baseline DAS28, then 9.4% of responders would be re-classified as non-responders, and 31.8% of non-responders would be re-classified as responders. The proportion of patients who had steroid treatment within the 3 months period before the baseline DAS28 did not differ significantly between the responders and non-responders (34% vs 41%, P = 0.38). Conclusion. Baseline DAS28 is critical in classifying responders at the 6-month assessment.Keywords
This publication has 7 references indexed in Scilit:
- Discrepancies between the EULAR response criteria and the NICE guidelines for continuation of anti-TNF therapy in RA: a cause for concern?Rheumatology, 2007
- Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centresRheumatology, 2007
- Update on the British Society for Rheumatology guidelines for prescribing TNF blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)Rheumatology, 2005
- The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysisArthritis & Rheumatism, 2004
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1992
- Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.Annals of the Rheumatic Diseases, 1990